Chao Yin-Xia, Gulam Muhammad Yaaseen, Chia Nicholas Shyh Jenn, Feng Lei, Rotzschke Olaf, Tan Eng-King
Department of Neurology, National Neuroscience Institute, Singapore, Singapore.
Department of Neurology, Singapore General Hospital, Singapore, Singapore.
Front Neurol. 2020 Aug 25;11:849. doi: 10.3389/fneur.2020.00849. eCollection 2020.
Increasing evidence suggests an association between gastrointestinal (GI) disorders and susceptibility and progress of Parkinson's disease (PD). Gut-brain axis has been proposed to play important roles in the pathogenesis of PD, though the exact pathophysiologic mechanism has yet to be elucidated. Here, we discuss the common factors involved in both PD and GI disorders, including genes, altered gut microbiota, diet, environmental toxins, and altered mucosal immunity. Large-scale prospective clinical studies are needed to define the exact relationship between dietary factors, microbiome, and genetic factors in PD. Identification of early diagnostic markers and demonstration of the efficacy of diet modulation and regulation of gut microbiome through specific therapeutics can potentially change the treatment paradigm for PD.
越来越多的证据表明,胃肠道(GI)疾病与帕金森病(PD)的易感性和病情进展之间存在关联。尽管确切的病理生理机制尚未阐明,但肠-脑轴已被认为在PD的发病机制中起重要作用。在这里,我们讨论了PD和GI疾病中共同涉及的因素,包括基因、肠道微生物群改变、饮食、环境毒素和黏膜免疫改变。需要大规模的前瞻性临床研究来确定饮食因素、微生物群和PD遗传因素之间的确切关系。识别早期诊断标志物以及通过特定疗法证明饮食调节和肠道微生物群调控的疗效可能会改变PD的治疗模式。